News

Medscape9y
Capsaicin Patch Approved in EU for Diabetic Neuropathy Pain
STOCKHOLM — Patients with diabetic peripheral neuropathy who used a capsaicin 8% patch (Qutenza, Astellas Pharma) had more relief from pain and better sleep quality than those who received a ...
Healthline2y
Capsaicin Creams, Patches & More
Prescription capsaicin patches work like other topicals but contain a higher concentration of capsaicin. According to a 2013 review, the capsaicin 8% prescription patch is used to manage ...
Monthly Prescribing Reference4y
Capsaicin 8% Safe and Effective for Diabetic Peripheral Nerve Pain Therapy
Credit: Getty Images. Investigators assessed the efficacy and tolerability of a high-concentration capsaicin 8% patch to treat diabetic peripheral nerve pain, either alone or in combination with ...
Monthly Prescribing Reference13y
Using Mechanical Pain Sensitivity to Target Responders to Capsaicin 8% Patch Treatment
PALM SPRINGS, CA — Capsaicin 8% patch is a novel therapy for the treatment of peripheral neuropathic pain. Researchers at the 2012 American Academy of Pain Medicine Annual Meeting reported on ...
FierceBiotech15y
NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
First and only prescription strength capsaicin product can provide up to 12 weeks of reduced pain from a single one-hour treatment SAN MATEO, Calif., Nov 16, 2009 /PRNewswire-FirstCall via COMTEX ...
Medindia15y
Qutenza(R) (capsaicin) 8% Patch for Treatment of Post-Shingles Pain Now Available
SAN MATEO, Calif., April 5 NeurogesX, Inc. (Nasdaq: NGSX) announced today that Qutenza (capsaicin) 8% patch, the first and only product containing prescription-strength capsaicin, is now available.
Europa Press9y
Astellas Granted Label Extension for QUTENZA[TM] (capsaicin 8% patch) to Include Treatment of Diabetic Patients With Per
Astellas Pharma Europe Ltd. today announced the European Commission has granted approval for a label extension for QUTENZA[TM] (capsaicin 8% patch) to include the treatment of adult diabetic ...
FierceBiotech13y
NeurogesX Provides Update on Qutenza(R) (Capsaicin) 8% Patch for New Indication to Treat HIV-PN Following FDA Advisory Committee
SAN MATEO, Calif., Feb 9, 2012 (GlobeNewswire via COMTEX) -- NeurogesX , a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain ...
Finanznachrichten15y
NeurogesX Receives FDA Approval of Qutenza (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN) / First and only prescription strength capsaicin product can ...
nasdaq 100 euro stoxx 50 ftse-100 ...
clinicaladvisor.com14y
NGX-4010, Capsaicin 8% Patch, Effective for Postherpetic Neuralgia in Older Population
AUSTIN, TX — Data presented at the American Pain Society’s 30 th Annual Scientific Meeting demonstrated that NGX-4010, a capsaicin 8% patch significantly reduces pain in older patients with ...
Medical News Today2y
6 of the best capsaicin creams
Experts consider products with 0.1% capsaicin high potency. The patches are prescription only, and doctors may prescribe an 8% capsaicin patch known as Qutenza. A Qutenza patch can work for up to ...
FiercePharma9y
Astellas Granted Label Extension for QUTENZA[TM] (capsaicin 8% patch) to Include Treatment of Diabetic Patients With Peripheral Neuropathic Pain (PNP)
Astellas Pharma Europe Ltd. today announced the European Commission has granted approval for a label extension for QUTENZA[TM] (capsaicin 8% patch) to include the treatment of adult diabetic ...